Skip to main content
SpringerLink
Log in

NICE draft guidance recommends vortioxetine for MDD

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • NICE. NICE draft guidance recommends vortioxetine (Brintellix) for treating major depressive episodes. Media Release : 16 Oct 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE draft guidance recommends vortioxetine for MDD. PharmacoEcon Outcomes News 739, 33 (2015). https://doi.org/10.1007/s40274-015-2551-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2551-6

Search

Navigation